shipment_ID,catalog_ID,Formula,stereochemistry,sample_MW,purity,PO,Salt_Name,Salt_ratio,MW_salt,volume(uL),concentration(mM),plate_ID,well,SMILES,Name,Batch ID,"Amount, mg (left)"
EDJ-MED-b6c6ee2b-2,Z5631110237,C25H25ClN4O3,Racemic or presumed racemic or meso,464.944,96,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-93,03_A,CNC(=O)CN1CC=2C=CC(Cl)=CC2C3(CCN(C3=O)C=4C=NC=C5C=CC(OC)=CC45)C1,"2-[6-chloro-1'-(6-methoxyisoquinolin-4-yl)-2'-oxo-2,3-dihydro-1H-spiro[isoquinoline-4,3'-pyrrolidin]-2-yl]-N-methylacetamide",H3777052,4.8
LUO-POS-e1dab717-12,Z5715580905,C26H25ClN4O4S,Racemic or presumed racemic or meso,525.019,96.68,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-93,03_B,ClC=1C=CC2=C(C1)C3(CCN(C3=O)C=4C=NC=C5C=CC=CC45)CN(CC(=O)NCC6CC6)S2(=O)=O,"2-[6-chloro-1'-(isoquinolin-4-yl)-1,1,2'-trioxo-2,3-dihydrospiro[1??,2-benzothiazine-4,3'-pyrrolidin]-2-yl]-N-(cyclopropylmethyl)acetamide",H3786289,35.6
MAT-POS-50a80394-1,Z5600473273,C27H25ClN4O3S,Diastereomeric mixture,521.030,100,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-93,03_C,CC1CN(C(=O)C21CN(CC=3C=CC(Cl)=CC32)S(=O)(=O)CC4(CC4)C#N)C=5C=NC=C6C=CC=CC56,"1-({[6-chloro-1'-(isoquinolin-4-yl)-4'-methyl-2'-oxo-2,3-dihydro-1H-spiro[isoquinoline-4,3'-pyrrolidin]-2-yl]sulfonyl}methyl)cyclopropane-1-carbonitrile",H3786286,95.8
LUO-POS-e1dab717-11,Z5715580895,C24H23ClN4O4S,Racemic or presumed racemic or meso,498.981,100,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-93,03_D,CCNC(=O)CN1CC2(CCN(C2=O)C=3C=NC=C4C=CC=CC34)C=5C=C(Cl)C=CC5S1(=O)=O,"2-[6-chloro-1'-(isoquinolin-4-yl)-1,1,2'-trioxo-2,3-dihydrospiro[1??,2-benzothiazine-4,3'-pyrrolidin]-2-yl]-N-ethylacetamide",H3786290,28.5
MAT-POS-50a80394-2,Z5600473274,C28H27ClN4O3S,Diastereomeric mixture,535.056,95,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-93,03_E,CCC1CN(C(=O)C21CN(CC=3C=CC(Cl)=CC32)S(=O)(=O)CC4(CC4)C#N)C=5C=NC=C6C=CC=CC56,"1-({[6-chloro-4'-ethyl-1'-(isoquinolin-4-yl)-2'-oxo-2,3-dihydro-1H-spiro[isoquinoline-4,3'-pyrrolidin]-2-yl]sulfonyl}methyl)cyclopropane-1-carbonitrile",H3786292,68.1
EDJ-MED-b6c6ee2b-3,Z5631110240,C27H25ClN4O4S,Racemic or presumed racemic or meso,537.029,96.91,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-93,03_F,COC=1C=CC=2C=NC=C(N3CCC4(CN(CC=5C=CC(Cl)=CC54)S(=O)(=O)CC6(CC6)C#N)C3=O)C2C1,"1-({[6-chloro-1'-(6-methoxyisoquinolin-4-yl)-2'-oxo-2,3-dihydro-1H-spiro[isoquinoline-4,3'-pyrrolidin]-2-yl]sulfonyl}methyl)cyclopropane-1-carbonitrile",H3781453,51.4
